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Abstract 
Background: Spinal anesthesia has been shown to be an easy, rapid 
and safe technique, nevertheless, it has some minor side effects, including 
intraoperative nausea and vomiting. Nausea, retching, and vomiting during 
regional anesthesia are common occurrences. The abrupt diaphragmatic 
contractions, present in emesis, are uncomfortable to the patient and may 
cause protrusion of the abdominal viscera, rendering surgery more difficult 
and increasing the risk of visceral injuries.  
Objectives: evaluation the effectiveness of low dose propofol for control of 
nausea and vomiting during spinal anesthesia. 
Patients and Method: After taking written informed consent, 83 Patients (79 
males and 4 females) of ASA physical status I or II, aged 23-80 years, 
scheduled for elective urosurgery in the Sulaimani teaching hospital were enrolled 
in a single blind prospective study. Patients were divided into two groups to 
receive either propofol (1 mg/kg/hr) or Intralipid (Placebo). Operations were 
performed under spinal anaesthesia. Patients were followed up for 24 hours for 
post operative nausea and vomiting.  
Results: Patients who received Propofol had statistically significant less 
nausea and vomiting than those who received Placebo (Intralipid).  
Conclusion: Propofol at a subhypnotic dose is effective in the prevention of 
nausea and vomiting.                                                                                                                                     
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Introduction                                                                                                    
 Nausea and vomiting has been a problem since the introduction of 
anesthesia (Hines et al; 1992). Despite the introduction of less invasive 
surgical procedures and new anesthetic agents, some patients can feel fine, 
without any problems during the initial period in the postoperative care unit, 
and then start to feel nauseated and possibly even vomit several hours later. 
Post operative nausea and vomiting is an important cause of delayed 
European Scientific Journal April 2015 edition vol.11, No.12  ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
338 
discharge from the recovery room and decreased patient satisfaction (Pavlin 
et al; 1998). Nausea and vomiting also associated with complications such as 
tension on suture lines, wound bleeding and dehiscence, increased 
intracranial pressure, pulmonary aspiration, dehydration and electrolyte 
imbalance (Myles et al ; 2000).  
 Mechanism of post operative nausea and vomiting (PONV) in 
regional anesthesia: 
 Hypotension is a common occurrence during neuraxial anesthesia. 
Low blood pressure may lead to brain stem ischemia, which is thought to 
activate the circulatory, respiratory, and vomiting centers grouped together in 
the medulla (Datta et al; 1982). Other investigators have speculated that 
hypotension rather leads to gut ischemia and the release of emetogenic 
substances (e.g., serotonin) from the intestines. Consequently, supplemental 
oxygen can relieve nausea in such circumstances by attenuating the release 
of serotonin from the vagal afferent nerves in the gastrointestinal tract 
through increasing oxygen concentration to the tissues, thus enhancing 
delivery of oxygen to the intestine (Racke & Schworer; 1991). Strategies 
avoiding hypotension were shown to be effective in reducing emesis 
(Borgeat et al; 2003).  
 Neuraxial anesthesia also changes the function of the gastrointestinal 
(GI) tract (Liu, Carpenter & Neal 1995). Sympathetic blockade by local 
anesthetics creates unopposed vagal action, resulting in GI hyperactivity. 
The efficacy of vagolytic agents to relieve nausea during spinal anesthesia 
has been taken as evidence of the importance of this mechanism (Borgeat et 
al; 2003).  
 Visceral pain is a potent stimulus for emetic symptoms during 
regional anesthesia. Handling of abdominal viscera stimulates sensory vagal 
fibers and induces emesis by activating the vomiting center (Yoshitaka; 
2007). 
 The choice of local anesthetic used for intrathecal injection does not 
influence PONV. Most investigations found no difference when comparing 
local anesthetics (Beilin et al; 2003), the dose of drug does not seem to 
influence the occurrence of PONV, as long as hypotension is avoided 
(Sheskey et al; 1983).  
 Propofol possesses direct antiemetic properties, which is not a result 
of the lipid emulsion in the formulation of propofol (Yoshitaka; 2007).The 
exact mechanism by which propofol acts as an antiemetic is unknown, but 
propofol is not considered to have vagolytic properties. In an experimental 
rat model, there is a possibility that the antiemetic property of propofol is 
associated with the reduced levels of serotonin in the area postrema and the 
CSF. Cechetto et al (2001) showed that propofol decreases the concentration 
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of both serotonin and 5-hydroxyindoleacetic acid within the fourth ventricle 
at the level of the area postrema.  
 
Patients and Methods 
 In a prospective, randomised, single blind, placebo-controlled, 
clinical investigation and after obtaining a written informed consent from the 
patients, 83 Patients of ASA physical status I or II, aged 22 – 80 years, 
scheduled for elective surgery in the Urology operating theatre / Sulaimani 
teaching hospital from 20th May 2009 to 1st October 2009 were enrolled in the 
study. Patients were randomly assigned into two groups to receive either a 
continuous infusion of propofol (43 cases) at a subhypnotic dose (1 
mg/kg/hr) or intralipid (40 cases). Patients with contraindications for spinal 
anaesthesia and/or with a history of sensitivity to propofol or intralipid, 
patients who have gastrointestinal diseases, ear diseases, liver diseases and 
those who have received drugs with antiemetic properties within 24 hours 
before surgery were not included in the study. 
 Every patient received 1 mg lorazepam preoperatively as premedication 
2 hours before the operation. All subjects had fasted for at least 8 hours. On 
arrival in the operating room, routine monitoring devices were attached, and 
baseline blood pressure, heart rate, and pulse oximetry values were recorded. Each 
patient received 1 Litre of Ringer’s lactate solution before spinal anaesthesia. 
 Under sterile conditions and via the midline approach dural puncture 
was performed at the L3 –L4 interspace with a 25 gauge spinal needle (Dr.J  
K-3 point type LUER-Lock HUB Tokyo Japan) in sitting position. After the 
free flow of CSF, 15-17.5 mg bupivacaine or 70-80 mg lidocaine was 
injected intrathecally, and then patients were placed in supine position 
immediately and kept horizontal for the remainder of the study, Oxygen 3 
litres per minute administered to the patients via face mask. Following 
confirmation of sensory block by loss of sensation to cold and pinprick 
surgery was started. ECG, SpO2, pulse rate, and arterial blood pressure were 
monitored and recorded. Blood pressure values of prespinal and 10, 20 and 
30 minutes postspinal were recorded for statistical purposes. The decrease in 
mean arterial blood pressure (more than 20% baseline value) after spinal 
injection was regarded as hypotension and treated by increasing the rate of 
intravenous fluid administration, and by 5-10 micrograms increments of 
adrenaline administered i.v. (every 3-5 minutes) until resolution of 
hypotension.  Heart rate < 60 bpm or 20% less than the baseline was defined 
as bradycardia and treated with 0.30 mg of i.v. atropine. The patients were 
advised to lie down in bed for 24 hours postoperatively to decrease the risk 
of Head ache and PONV. 
Within 24 hours of surgery, PONV episodes were identified by direct 
questioning or by spontaneous complaint by the patients. If two or more 
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episodes of nausea-vomiting occurred, 10 mg of metoclopromide was 
provided intravenously as rescue antiemetic treatment. Postoperative 
analgesia was accomplished by NSAIDS except for those with greater risk of 
bleeding (20 out of 83 cases) in whom opioids were used instead.  
 Data were translated into codes using a specially designed coding 
sheet, and then converted to computerized database. An expert statistical 
advice was sought and statistical analyses were done using Statistical 
Package for Social Science (SPSS) version 13 computer software. The 
degree of association between the variables was calculated using Rank 
correlation i.e. Spearman's rho and/or Kendall's tau rank correlation 
coefficients. P value was calculated by Chi square and a P value of less than 
0.05 was considered as statistically significant. 
 
Results 
 Patients were divided in to two groups to receive either propofol 
(51.8% of patients) or intralipid (48.1% of patients), the intrathecal injection 
of local anesthetic   (LA) agent was almost in two-thirds for Bupivacaine and 
a third for lidocaine, as shown in table 1. 
Table 1 shows number and percentage of propofol, intralipid, 
Bupivacaine and lidocaine receiving patients 
Variable Frequency Percentage (%) 
Research Drug 
Propofol 
Intralipid 
 
43 
40 
 
51.81 
48.19 
LA agent 
Bupivacaine 
Lidocaine 
 
56 
27 
 
67.4 
32.6 
 
 There was no statistically significant difference between the 
intrathecally injected local anaesthetic agent in regard to PONV or 
hypotension as shown in table 2. 
Table 2: Shows Lidocaine/ Bupivacaine relation to PONV and hypotension 
 
LA agent 
 
Hypotension 
P value 
PONV 
P value No 
No. (%) 
Yes 
No. (%) 
No 
No. (%) 
Yes 
No. (%) 
Lidocaine 
Bupivacaine 
25(92.6) 
54(96.4) 
2(7.4) 
2(3.6) 0.593 
24(88.8) 
43(76.78) 
3(11.2) 
13(23.22) 0.156 
 
 The frequency and percentage of patients who suffered from 
hypotension, head ache and PONV is shown in table 3. 
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Table 3 shows the frequency and percentage of hypotension, PONV and Head ache 
 
 
 
 
 
 
 
 
 
 
Hypotension was not a significant factor in relation to head ache or 
PONV, Table 4 
Table 4: Shows Hypotension relation to head ache and PONV 
Variables 
Head ache 
P value 
PONV 
P value No 
No. (%) 
Yes 
No. (%) 
No 
No. (%) 
Yes 
No. (%) 
Hypotension 
Yes 
No 
4(100.0) 
66(83.5) 
0(0.0) 
13(16.5) 
0.899 3(75.0) 
64(81.0) 
1(25.0) 
15(19.0) 
0.583 
 
 The percentage of female patients who suffered from Head ache and 
PONV is more than their male counterparts but the results were not 
statistically significant. These results are shown in table 5.    
Table 5: Shows PONV and head ache distribution in relation to gender 
gender 
Head ache 
P value 
PONV 
P value No 
No. (%) 
Yes 
No. (%) 
No 
No. (%) 
Yes 
No. (%) 
Male 
Female 
61(84.7) 
8(80.0) 
11(15.3) 
2(20.0) 0.497 
58(80.6) 
8(80.0) 
14(19.4) 
2(20.0) 0.625 
 
 Age as a contributing factor was not statistically significant in the 
occurrence of hypotension, head ache, nausea and vomiting. These results 
are shown in table 6.  
 
 
 
 
 
 
 
 
 
Variables Frequencies Percentage (%) 
Hypotension 
No 
Yes 
 
79 
4 
 
95.2 
4.8 
Head ache 
No 
Yes 
 
70 
13 
 
84.3 
15.7 
PONV 
No 
Yes 
 
67 
16 
 
80.7 
19.3 
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Table 6: Age relation to PONV, head ache and hypotension. 
 
Opioid use for control of postoperative pain was associated with a 
relatively higher incidence of PONV, but the result was not statistically 
significant. As shown in table 7. 
Table 7: Shows Opioid relation to PONV 
Opioid 
options 
Research Drug 
P value 
PONV 
P value Propofol 
No. (%) 
Intralipid 
No. (%) 
No 
No. (%) 
Yes 
No. (%) 
Non opioid 
used 
Opioid used 
34(54.0) 
9(45.0) 
     
29(46.0) 
11(55.0) 
0.484 
 
53(84.1) 
14(70.0) 
   10(15.9) 
6(30.0) 
0.163 
 
 Propofol was effective in reducing the incidence of PONV, this result 
was statistically significant, but there was no statistically significant 
difference between the relation of propofol or intralipid to headache. These 
facts are shown in table 8. 
Table 8: Shows the effect of Propofol on the incidence of PONV. 
 
Research drug 
 
Head ache 
P value 
PONV 
P value No 
No. (%) 
Yes 
No. (%) 
No 
No. (%) 
Yes 
No. (%) 
Propofol 
Intralipid 
35(81.4) 
35(87.5) 
8(18.6) 
5(12.5) 0.455 
38(88.4) 
29(72.5) 
5(11.6) 
11(27.5) 0.04 
 
Discussion 
 Reviews dealing with PONV have discussed almost exclusively GA 
and largely ignored regional anesthesia (Borgeat et al; 2003, Watcha & 
White; 1992). This contrasts with the increasing popularity of regional 
anesthesia. A survey in Europe showed that one third of patients are 
undergoing regional anesthesia for their operative procedure (Borgeat et al; 
2003), therefore I planned to investigate PONV among patients who 
underwent surgery under spinal anaesthesia. 
 Patients who received propofol had statistically significant lower 
incidence of PONV than those who received the placebo (Intralipid). This 
Variables Age (years) Mean ± Std. Deviation P value 
Hypotension 
Yes 
No 
62.00 ± 2.449 
53.16 ± 16.626 
0.181 
Head ache 
No 
Yes 
15.674 ± 54.91 
46.46 ±18.577 
0.087 
PONV 
No 
Yes 
52.33 ± 16.472 
58.88 ± 15.090 
0.294 
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result agrees with that of studies of Doze et al (1988) observed a 20% 
incidence of PONV in patients receiving propofol-nitrous oxide versus 40% 
in those receiving thiopental-nitrous oxide also Raftery and Sherry (1992) 
assessed the incidence of PONV in 80 patients, they received either total 
intravenous anaesthesia with propofol or enflurane-nitrous oxide anaesthesia, 
the former was associated with less PONV. 
 There was no statistically significant difference between patients who 
received Lidocaine or Bupivacaine neither in PONV nor in hypotension. 
This result has been proved in the study of Beilin et al(2003) where they 
randomized 59 women to receive either spinal lidocaine 30 mg or 
bupivacaine 5.25 mg for cervical cerclage, they observed that the incidence 
of the complications of nausea, vomiting, hypotension, and the need for 
ephedrine did not differ significantly between the Bupivacaine and lidocaine 
groups.  
 Patients who used opioid analgesia had relatively more incidence of 
PONV than others but the difference was not statistically significant, this 
result disagrees with that observed by Roberts et al (2005) who have 
confirmed, in a prospective study among 193 patients, that the incidence of 
nausea and vomiting are both increased in a dose-dependent manner by the 
amount of opiate administered .This disagreement may be attributed to the 
small number of patients who received opioid analgesia or the antiemetic 
effect of propofol in the group where the propofol was used as research drug 
might have some residual antiemetic effect, yet another reason may be due to 
the fact that opioid analgesia had been given by i.m. route which has less 
emetogenic effect (Watcha & White; 1992). The explanation of more PONV 
in opioid-using patients may be, despite the opioid induced, due to the fact 
that the operations were more extensive in this group of patients and it is 
well-known that more visceral manipulation results in higher incidence of 
PONV (Borgeat et al; 2003, Yoshitaka; 2007).(6,8) 
 Age was not important as a risk factor for PONV or head ache. This 
agrees with the study of Koivuranta et al (1997) who in a prospective 
interview-based survey on the incidence of PONV in 1107 in-patients aged 
4-86 years found that the most important predictive factors associated with 
an increased risk for nausea and vomiting were female gender, a previous 
history of postoperative sickness, a longer duration of surgery, nonsmoking 
and a history of motion sickness with no effect of age. 
 Although female patients had more PONV and head ache than their 
male counterparts but the results were not statistically significant, this result 
disagrees with that of Larsson et al (1995) who performed a prospective 
study on 421 patients subjected to routine general-, orthopedic, urologic, 
gynecological and pediatric surgery to estimate the current incidences of 
nausea and vomiting during the first 24 hours after surgery. Postoperative 
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emetic symptoms were not related to age and women had more emetic 
symptoms than men, this disagreement may be due to the small number of 
female patients that have been included in our study or for better 
hemodynamic control. 
 Hypotension was not significant as a causative agent of head ache or 
PONV, this result disagrees with the result of Vercauteren et al (2000) who 
found that avoiding hypotension by ephedrine among 50 parturients 
undergoing C/S effectively reduce the incidence of PONV, this discrepancy 
may be due to early and effective hemodynamic control or good adherence 
of patients to our advice in regard to staying in bed. 
 
Conclusion  
 Propofol infusion at a subhypnotic dose of 1 mg/kg/hr is effective in 
reducing PONV, in operations under subarachnoid block to gain antiemetic 
effect.  
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